发明公开
EP2487176A1 Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
审中-公开
Makrozyklische Integrasehemmer zur Verwendung bei der Behandlung von felinem Immundefizienz-Virus
- 专利标题： Macrocyclic integrase inhibitors for use in the treatment of feline immunodeficiency virus
- 专利标题（中）： Makrozyklische Integrasehemmer zur Verwendung bei der Behandlung von felinem Immundefizienz-Virus
-
申请号： EP11154265.0申请日： 2011-02-14
-
公开(公告)号： EP2487176A1公开(公告)日： 2012-08-15
- 发明人: Thuring, Johannes Wilhelmus John F.
- 申请人： Elanco Animal Health Ireland Limited
- 申请人地址： 70 Sir John Rogerson's Quay Dublin IE
- 专利权人： Elanco Animal Health Ireland Limited
- 当前专利权人： Elanco Animal Health Ireland Limited
- 当前专利权人地址： 70 Sir John Rogerson's Quay Dublin IE
- 代理机构： Bassinder, Emma Marie
- 主分类号： C07D471/18
- IPC分类号： C07D471/18 ; C07D513/18 ; C07D471/22 ; C07D498/22 ; C07D515/18 ; A61K31/439 ; A61K31/4995 ; A61P31/14
摘要：
This invention concerns to naphthyridin derivatives of formula (I) for use in the treatment or prevention of feline immunodeficiency virus (FIV). Furthermore the present invention relates to a method of treating or preventing infection of feline immunodeficiency virus in a feline animal wherein said method comprises the administration to said feline animal of a therapeutically effective amount of a naphthyridin derivative.
信息查询
